Roles of lipoarabinomannan in the pathogenesis of tuberculosis

Microbes and Infection

Volumn 1, Issue 9, 1999, Pages 709-717

  Strohmeier, Gregg R ^a   Fenton, Matthew J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Lipoarabinomannan; Macrophage; Mycobacteria; Tuberculosis

Indexed keywords

ARABINOMANNAN; CYTOKINE; GLYCOLIPID; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; HUMAN; LEUKOCYTE FUNCTION; MACROPHAGE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0032695546     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80072-0     Document Type: Review

References (63)

1. Chatterjee D., Khoo K. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology. 8:1998;113-120.
2. Schluger N.W., Rom W.N. The host immune response to tuberculosis. Am. J. Respir. Crit. Care M. 157:1998;679-691.
3. Fenton M.J. Macrophages and tuberculosis. Curr. Opin. Hematol. 5:1998;72-78.
4. Hernandez-Pando R., Orozco H., Arriaga K., Sampieri A., Larriva-Sahd J., Madrid-Marina V. Analysis of the local kinetics and localization of interleukin-1 alpha, tumor necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology. 90:1997;607-617.
5. Orme I.M. Immunity to mycobacteria. Curr. Opin. Immunol. 5:1993;497-502.
6. Julian E., Matas L., Ausina V., Luquin M. Detection of lipoarabinomannan antibodies in patients with newly acquired tuberculosis and patients with relapse tuberculosis. J. Clin. Microbiol. 35:1997;2663-2664.
7. Berman J., Blumenthal R.L., Kornfeld H., Cook J., Cruikshank W., Vermeulen M.W., Chatterjee D., Belisle J., Fenton M.J. Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. J. Immunol. 156:1996;3828-3835.
8. Ernst W., Maher J., Cho S., Niazi K.R., Chatterjee D., Moody D.B., Besra G.S., Watanabe Y., Jensen P.E., Porcelli S.A., Kronenberg M., Modlin R.L. Molecular interaction of CD1b with lipoglycan antigens. Immunity. 8:1998;331-340.
9. Zhang Y., Lin Y., Iyer D., Gong J., Abrams J., Barnes P. T-cell cytokine responses in human infection with Mycobacterium tuberculosis infection. Infect. Immun. 63:1995;3231-3234.
10. Besra G.S., Brennan P.J. The mycobacterial cell wall: biosynthesis of arabinogalactan and lipoarabinomannan. Biochem. Soc. Trans. 25:1997;845-850.
11. Khoo K., Dell A., Morris H., Brennan P.J., Chatterjee D. Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology. 5:1995;117-127.
12. Chatterjee D., Lowell K., Rivoire B., McNeil M., Brennan P.J. Lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem. 267:1992;6234-6239.
13. Venisse A., Riviere M., Vercauteren J., Puzo G. Structural analysis of the mannan region of lipoarabinomannan from Mycobacterium bovis BCG. Heterogeneity in phosphorylation state. J. Biol. Chem. 270:1995;15012-15021.
14. Khoo K., Dell A., Morris H., Brennan P.J., Chatterjee D. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J. Biol. Chem. 270:1995;12380-12389.
15. Venisse A., Fournie J., Puzo G. Mannosylated lipoarabinomannan interacts with phagocytes. Eur. J. Biochem. 231:1995;440-447.
16. Khoo K., Douglas E., Azadi P., Inamine J.M., Besra G.S., Mikusova K., Brennan P.J., Chatterjee D. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol. J. Biol. Chem. 271:1996;28682-28690.
17. Mikusova K., Slayden R., Besra G.S., Brennan P.J. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicro. Agents Chemo. 39:1995;2484-2489.
18. Deng L., Mikusova K., Robuck K., Scherman M., Brennan P.J., McNeil M. Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicro. Agents Chemo. 39:1995;694-701.
19. Besra G.S., Morehouse C., Rittner C., Waechter C., Brennan P.J. Biosynthesis of mycobacterial lipoarabinomannan. J. Biol. Chem. 272:1997;18460-18466.
20. Schlesinger L., Hull S., Kaufman T. Binding of terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152:1994;4070-4079.
21. Kang B., Schlesinger L. Characterization of mannose receptor-dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan. Infect. Immun. 66:1998;2769-2777.
22. Schlesinger L., Kaufman K., Iyer S., Hull S., Marchiando L. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J. Immunol. 157:1996;4568-4575.
23. Peterson P., Gekker G., Hu S., Sheng W., Erson W., Ulevich R., Tobias P., Gustafson K., Molitor T., Chao C. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun. 63:1995;1598-1602.
24. Bernardo J., Billingslea A., Blumenthal R.L., Seetoo K., Simons E., Fenton M.J. Differential responses of human mononuclear phagocytes to mycobacterial lipoarabinomannans: role of CD14 and the mannose receptor. Infect. Immun. 66:1998;28-35.
25. Zhang Y., Doerfler M., Lee T.C., Guillemin B., Rom W.N. Mechanisms of stimulation of interleukin 1 beta and tumor necrosis factor alpha by Mycobacterium tuberculosis components. J. Clin. Invest. 91:1993;2076-2083.
26. Pugin J., Heumann I., Tomasz A., Kravchenko V., Akamatsu Y., Nishijima M., Glauser M., Tobias P., Ulevitch R. CD14 is a pattern recognition receptor. Immunity. 1:1994;509-516.
27. Savedra R.J., Delude R.L., Ingalls R., Fenton M.J., Golenbock D.T. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J. Immunol. 157:1996;2549-2554.
28. Ilangumaran S., Arni S., Poincelet M., Theler J.C., Brennan P.J., Nasir-Ud-Din, Hoessli D.E. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J. Immunol. 155:1995;1334-1342.
29. Prigozy T., Sieling P., Clemens D., Stewart P., Behar S., Porcelli S., Brenner M., Modlin R., Kronenberg M. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. 6:1997;187-197.
30. Sieling P., Chatterjee D., Porcelli S., Prigozy T., Mazzaccaro R., Soriano T., Bloom B., Brenner M., Kronenberg M., Brennan P., Modlin R. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science. 269:1995;227-230.
31. + T cells. Nature. 372:1994;691-694.
32. Fairhurst R.M., Wang C., Sieling P.A., Modlin R.L., Braun J. CD1-restricted T cells and resistance to polysaccharide-encapsulated bacteria. Immunol. Today. 19:1998;257-259.
33. Taylor M. Recognition of complex carbohydrates by the macrophage mannose receptor. Biochem. Soc. Trans. 21:1993;468-473.
34. Stokes R., Speert D. Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J. Immunol. 155:1995;1361-1369.
35. Schlesinger L. Mycobacterium tuberculosis and the complement system. Trends Micro. 6:1998;47-49.
36. Schorey J., Carroll M., Brown E. A macrophage invasion mechanism of pathogenic mycobacteria. Science. 277:1997;1091-1093.
37. Zimmerli S., Edwards S., Ernst J.D. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am. J. Resp. Cell Mol. Biol. 15:1996;760-770.
38. Fratazzi C., Arbeit R.D., Carini C., Remold H.G. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacteria growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158:1997;4320-4327.
39. Clemens D. Characterization of the Mycobacterium tuberculosis phagosome. Trends Micro. 4:1996;113-118.
40. Russell D., Sturgill-Koszycki S., Vanheyingen T., Collins H., Schaible U. Why intracellular parasitism need not be a degrading experience for Mycobacterium. Phil. Trans. R. Soc. Lond. 352:1997;1303-1310.
41. Russell D., Dant J., Sturgill-Koszycki S. Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J. Immunol. 156:1996;4764-4773.
42. Xu S., Cooper A., Sturgill-Koszycki S., vanHeyningen T., Chatterjee D., Orme I., Allen P., Russell D. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J. Immunol. 153:1994;2568-2578.
43. Russell D. Release and trafficking of lipid components from mycobacterial phagosomes in infected macrophages. Presented at the Keystone conference, TB: Molecular Mechanisms and Immunologic Aspects, Keystone, Colorado. 1998.
44. Keane J., Balcewicz-Sablinska M., Remold H., Chupp G., Meek B., Fenton M.J., Kornfeld H. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:1997;298-304.
45. Rojas M., Barrera L.F., Garcia L.F. Induction of apoptosis in murine macrophages by Mycobacterium tuberculosis is reactive oxygen intermediates-independent. Biochem. Biophys. Res. Commun. 247:1998;436-442.
46. Fratazzi C., Arbeit R.D., Carini C., Remold H.G. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158:1997;4320-4327.
47. Adams L., Fukutomi Y., Krahenbuhl J. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect. Immun. 61:1993;4173-4181.
48. Dahl K., Shiratsuchi H., Hamilton B., Ellner J., Toossi Z. Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun. 64:1996;399-405.
49. Appelberg R., Sarmento A., Castro A. Tumour necrosis factor-alpha in the host resistance to mycobacteria of distinct virulence. Clin. Exp. Immunol. 101:1995;308-313.
50. Barnes P., Chatterjee D., Abrams J., Lu S., Wang E., Yamamura M., Brennan P., Modlin R. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J. Immunol. 149:1992;541-547.
51. Knutson K., Hmama Z., Herrera-Velit P., Rochford R., Reiner N. Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes: role of Src homology 2 containing tyrosine phosphatase 1. J. Biol. Chem. 273:1998;645-652.
52. Takeuchi M., Alard P., Streilein J. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160:1998;1589-1597.
53. Kaplan G., Gandhi R.R., Weinstein D.S., Levis W.R., Patarroyo M.E., Brennan P.J., Cohn Z.A. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J. Immunol. 138:1987;3028-3034.
54. Chujor C.S.N., Kuhn B., Schwerer B., Bernheimer H., Levis W.R., Bevek D. Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen. Clin. Exp. Immunol. 8:1992;398-403.
55. Moreno C., Mehlert A., Lamb J. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin. Exp. Immunol. 74:1988;206-210.
56. Yoshida A., Koide Y. Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages. Infect. Immun. 65:1997;1953-1955.
57. Vouret-Craviari V., Matteucci C., Peri G., Poli G., Introna M., Mantovani A. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Infect. Immun. 65:1997;1345-1350.
58. Vouret-Craviari V., Cenzuales S., Mantovani A. Expression of monocyte chemotactic protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Cytokine. 9:1997;992-998.
59. Zhang Y., Broser M., Cohen H., Brodkin M., Law K., Reibman J., Rom W.N. Enhanced Interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest. 95:1995;586-592.
60. Roach T.I., Barton C.H., Chatterjee D., Blackwell J.M. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, tumor necrosis factor-α J. Immunol. 150:1993;1886-1896.
61. Riedel D., Kaufmann S. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect. Immun. 65:1997;4620-4623.
62. Cassidy J.P., Bryson D.G., Pollock J.M., Evans R.T., Forster F., Neill S.D. Early lesion formation in cattle experimentally infected with Mycobacterium bovis. J. Comp. Pathol. 119:1998;27-44.
63. Kurashima K., Mukaida N., Fujimura M., Yasui M., Nakazumi Y., Matsuda T., Matushima K. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am. J. Resp. Crit. Care M. 155:1997;1474-1477.